Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 32, Issue 14, Pages 2837-2848Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.05853-11
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [NS057105, P30 DK56341, AG13730, NS040745]
- HOPE Center for Neurological Disorders
- Division of Hematology and Oncology, Cincinnati Children's Hospital Medical Center
Ask authors/readers for more resources
AMP activated protein kinase (AMPK) plays a key role in the regulatory network responsible for maintaining systemic energy homeostasis during exercise or nutrient deprivation. To understand the function of the regulatory beta 2 subunit of AMPK in systemic energy metabolism, we characterized beta 2 subunit-deficient mice. Using these mutant mice, we demonstrated that the beta 2 subunit plays an important role in regulating glucose, glycogen, and lipid metabolism during metabolic stress. The beta 2 mutant animals failed to maintain euglycemia and muscle ATP levels during fasting. In addition, beta 2-deficient animals showed classic symptoms of metabolic syndrome, including hyperglycemia, glucose intolerance, and insulin resistance when maintained on a high-fat diet (HFD), and were unable to maintain muscle ATP levels during exercise. Cell surface-associated glucose transporter levels were reduced in skeletal muscle from beta 2 mutant animals on an HFD. In addition, they displayed poor exercise performance and impaired muscle glycogen metabolism. These mutant mice had decreased activation of AMPK and deficits in PGC1 alpha-mediated transcription in skeletal muscle. Our results highlight specific roles of AMPK complexes containing the beta 2 subunit and suggest the potential utility of AMPK isoform-specific pharmacological modulators for treatment of metabolic, cardiac, and neurological disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available